Connection

JAMES C YAO to Drug Synergism

This is a "connection" page, showing publications JAMES C YAO has written about Drug Synergism.
Connection Strength

0.119
  1. Potential synergies for combined targeted therapy in the treatment of neuroendocrine cancer. Drugs. 2011 May 07; 71(7):841-52.
    View in: PubMed
    Score: 0.073
  2. Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity. Cancer Res. 2010 Feb 01; 70(3):1111-9.
    View in: PubMed
    Score: 0.017
  3. Targeted inhibition of Sp1-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse models. Int J Oncol. 2008 Jul; 33(1):161-7.
    View in: PubMed
    Score: 0.015
  4. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A. Cancer Res. 2007 May 15; 67(10):4878-85.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.